Ria Treatment Platform: combined medication, coaching, education, and monitoring
Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.
| Facility | City | Region | Status |
|---|---|---|---|
| Stanford University | Stanford | California |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05747703 on ClinicalTrials.gov ↗ ← All trials in the USA